CYTORI THERAPEUTICS, INC. TO SELL $16.8 MILLION OF COMMON STOCK TO OLYMPUS CORPORATION AND INSTITUTIONAL INVESTORS

Therapeutics, Inc. announced it has entered into agreements to raise approximately $16.8 million through the sale of 2,918,255 shares of common stock to Olympus Corporation as well as new and existing institutional investors at $5.75 per share. Olympus has agreed to purchase a total of 1,913,043 shares. The purchase price was determined by Cytori's closing price on August 9, 2006. BioSpace (http://www.biospace.com/news_story.aspx?StoryId=27017)